Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Bimatoprost is safe and effective for improving eyebrow hair.

New compounds may soon be tested to treat excessive hair growth in women.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

A certain inhibitor can slow down the decrease in DNA creation in mouse hair follicles, which might help with hair growth.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.